MYnd Analytics Inc. (MYND) Director Buys $54,750.00 in Stock
MYnd Analytics Inc. (NASDAQ:MYND) Director Peter Unanue acquired 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 6th. The shares were acquired at an average price of $3.65 per share, for a total transaction of $54,750.00. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.
Shares of MYnd Analytics Inc. (MYND) traded up $0.11 during trading hours on Wednesday, hitting $3.80. 25,887 shares of the company’s stock traded hands, compared to its average volume of 23,499. MYnd Analytics Inc. has a 12 month low of $2.80 and a 12 month high of $9.45.
Separately, Maxim Group reiterated a “buy” rating and set a $18.00 price objective on shares of MYnd Analytics in a research note on Tuesday, September 26th.
COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/12/06/mynd-analytics-inc-mynd-director-buys-54750-00-in-stock.html.
MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.
Receive News & Ratings for MYnd Analytics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.